News

Yahoo Finance4mon
Beta Lactam and Beta Lactamase Inhibitors Market to grow by USD 8.4 Billion from 2025-2029, driven by novel drug development, with AI driving market transformation - Technavio
These advancements contribute to the discovery of improved beta lactam antibiotics and beta lactamase inhibitors, addressing antimicrobial resistance and infectious diseases.
PharmiWeb3y
Beta-lactam and Beta-lactamase Inhibitors Market: Global Opportunity Analysis, Key Stakeholders and Industry Forecast 2022 to 2028
From 2022 to 2028, Global Beta-lactam and Beta-lactamase Inhibitors Market by MarketsandResearch.biz presents an overview of the current development environment as well as the industry’s future growth ...
Business Insider5y
The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from ...
NEW YORK, Oct. 1, 2019 /PRNewswire/ -- Beta-lactam and Beta-lactamase Inhibitors Market by Drug Class (Penicillin, Cephalosporin, Carbapenem, Monobactam, and Combination), Disease (Urinary Tract ...
Yahoo Finance2y
The Global Beta Lactam and Beta Lactamase Inhibitors Market is expected to grow by $ 9.04 bn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period
New York, July 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Beta Lactam and Beta Lactamase Inhibitors Market 2022-2026" - https://www.reportlinker.com ...
PharmiWeb4y
Beta-lactam and Beta-lactamase Inhibitors Market to Cross $34,170 Million by 2028
Pune, Maharashtra, India, December 17 2020 (Wiredrelease) Allied Analytics –:Increase in demand for antimicrobial resistance medication play a major role in the growth of the beta-lactam and ...
Business Insider5y
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34.17 Bn, Globally, by 2028 at 2.3% CAGR: Allied Market Research
According to the report, the global beta-lactam and beta-lactamase inhibitors industry generated $27.12 billion in 2018, and is expected to reach $34.17 billion by 2028, registering a CAGR of 2.3% ...
Mena FN1y
Asia-Pacific Is Expected To Remain Dominant In The Global Beta-Lactam And Beta-Lactamase Inhibitors Market 2019 To 2028
Asia-Pacific region emerged as the primary revenue generator for the worldwide beta-lactam and beta-lactamase inhibitors market in 2018 PORTLAND, OREGON, UNITED STATES, July 17, 2023/einpresswire ...